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Given that the genetic risk for schizophrenia is highly polygenic and the effect sizes, even
for rare or de novo events, are modest at best, it has been suggested that multiple
biological pathways are likely to be involved in the etiopathogenesis of the disease. Most
efforts in understanding the cellular basis of schizophrenia have followed a “neuron-
centric” approach, focusing on alterations in neurotransmitter systems and synapse
cytoarchitecture. However, multiple lines of evidence coming from genetics and systems
biology approaches suggest that apart from neurons, oligodendrocytes and potentially
other glia are affected from schizophrenia risk loci. Neurobiological abnormalities linkedwith
genetic association signal could identify abnormalities that are more likely to be primary,
versus environmentally induced changes or downstream events. Here, we summarize
genetic data that support the involvement of oligodendrocytes in schizophrenia, providing
additional evidence for a causal role with the disease. Given the undeniable evidence of
both neuronal and glial abnormalities in schizophrenia, we propose a neuro-glial model that
invokes abnormalities at the node of Ranvier as a functional unit in the etiopathogenesis
of the disease.
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INTRODUCTION
The core symptoms of schizophrenia include the presence of
delusions and hallucinations (positive symptoms), apathy, and
social withdrawal (negative symptoms), as well as, stable impair-
ments in speciﬁc domains of cognitive function. Despite our best
effort, we still lack a basic understanding of the etiopathogenesis
of schizophrenia and therefore tools for curative treatment or pre-
vention do not exist (Insel, 2010). Given the high prevalence of
schizophrenia (1% or more) the need for greater understanding is
urgent.
Most efforts in understanding the cellular basis of schizophre-
nia have followed a “neuron-centric” approach, focusing exclu-
sively on the role(s) of neurons. This has led to ﬁndings of
alterations in neuronal function, such as neurotransmission and
synapse cytoarchitecture, often overlooking the fact that neu-
ronal function and neurotransmission is inextricably dependent
on interactions between neurons and glia. Increasing recogni-
tion of the importance of neuro-glial elements as basic functional
units (Allen and Barres, 2009) that participate in CNS func-
tion and dysfunction combined with multiple lines of evidence
showing abnormalities in oligodendrocytes and myelination have
implicated oligodendrocytes as highly relevant to schizophrenia.
While the approach of grouping neurons and glia into neuro-
glial functional units introduces signiﬁcant complexity into the
analysis of the neurobiology of schizophrenia, it encourages an
integrative approach that favors the examination of the interplay
between neurons and the more abundant glial cell types of the
CNS.
Here, we ﬁrst outline genetic evidence derived from candi-
date gene association studies or genome-wide approaches that
support oligodendroglial and myelin related (OMR) abnormal-
ities in schizophrenia as a primary contributor. In an attempt
to provide a mechanistic and integrative interpretation of the
neuronal and OMR changes in schizophrenia, we introduce a
neuro-oligodendroglial model that involves abnormalities at the
nodes of Ranvier (NOR) as a functional unit implicated in the
etiopathogenesis of the disease.
MYELIN ASSOCIATED ABNORMALITIES IN SCHIZOPHRENIA
Myelination can increase action potential transmission speed and
decrease refractory time, which increases the number of action
potentials that can be transmitted per unit time. There is accu-
mulating evidence supporting the notion of schizophrenia as a
disorder of disconnectivity (Konrad and Winterer, 2008). While
disconnectivity can be caused by different mechanisms, such as
synaptic malfunction, at its core, it implicates inadequate or
failed information transfer among neurons. OMR abnormalities
in schizophrenia impair the saltatory conduction and information
conduction from one neuron to others.
Growing evidence, accumulated over the last 15 years, pro-
vide strong support for OMR abnormalities in schizophrenia.
The majority of those data is derived from neuroimaging and
human postmortem studies (for review, see Sequeira et al., 2012;
Fitzsimmons et al., 2013). Irrespective of the level of care and
control, different confounding factors, such as antipsychotic med-
ication, could contribute to the detected OMR neuroimaging,
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gene expression, and proteome abnormalities in schizophrenia.
Therefore, incorporating genetic data, as discussed below, can
help distinguish whether OMR changes are a primary contribu-
tor to disease pathophysiology vs. secondary changes associated
with other primary lesions existing in schizophrenia or mere
epiphenomena.
GENETIC ASSOCIATION OF OMR CANDIDATE GENES IN
SCHIZOPHRENIA
Multiple candidate studies have provided evidence that OMR
genes are genetically associated with schizophrenia (Table 1). It
is interesting to note, that the products of these same genes have
been implicated in numerous direct studies of OMR gene and
protein expression in the brains of persons with schizophrenia, as
well as, neuroimaging studies, providing a stronger support for
causality with the disease (Bartzokis, 2011; Takahashi et al., 2011).
The OMR genes with the strongest support for genetic association
with schizophrenia are described below:
Neuregulin 1 (NRG1) – ERBB4 signaling
NRG1 risk genotypes or haplotypes have been associated with
schizophrenia (Stefansson et al., 2002). Genetic evidence also sup-
ports ERBB4 – the NRG1 receptor – as a candidate susceptibility
gene and suggests positive epistatic interactions between NRG1
and ERBB4 in schizophrenia (Norton et al., 2006). The potential
pathophysiologic role of NRG1 is further supported by its diverse
neurobiological functions, including neuro-glial trophic effects
and myelination (Harrison and Law, 2006). Nevertheless, given
the fact that the NRG1 – ERBB4 signaling has multiple effects in
nervous system development (including neuronal migration and
modulation of neurotransmission), this pathwaymay play a role in
schizophrenia pathogenesis through othermechanisms aside from
OMR effects. A direct way to assess the pathophysiologic effects
of genetic variants would be to examine human subjects with
risk variants for symptoms of schizophrenia. Along these lines,
many groups have reported association of the NRG1 – ERBB4 risk
variants with neurocognitive (Stefanis et al., 2007), electrophys-
iological (Roussos et al., 2011) and neuroimaging schizophrenia-
related outcomevariables, including altered fronto-temporal brain
function (Hall et al., 2006) and white matter density and integrity
(McIntosh et al., 2008; Konrad et al., 2009). Finally, several groups
have assessed gene expression and proteins of NRG1 and ERBB4
in postmortem brains and have reported differences between
schizophrenia and healthy control groups (Hashimoto et al., 2004;
Law et al., 2006).
Disrupted-in-schizophrenia 1
Disrupted-in-schizophrenia 1 (DISC1) is a strong candidate gene
for schizophrenia and was initially identiﬁed in a large Scottish
pedigree (Millar et al., 2000) followed by additional genetic evi-
dence for association with sporadic cases of schizophrenia (Chubb
et al., 2008). Recent studies in zebraﬁsh (Drerup et al., 2009)
and transgenic mice (Katsel et al., 2011) with forebrain restricted
expression of mutant human DISC1 have suggested a critical role
for DISC1 in oligodendroglial differentiation during neurodevel-
opment. In human postmortem analyses, DISC1 transcripts that
are more abundant during fetal development are upregulated in
the hippocampus of patients with schizophrenia and their expres-
sion levels are associated with schizophrenia risk DISC1 polymor-
phisms (Nakata et al., 2009). One of those risk DISC1 SNPs is
also associated with white matter integrity as measured by DTI
(Sprooten et al., 2011).
Reticulon 4 receptor
Reticulon 4 receptor (RTN4R) is a myelin-associated protein that
inhibits the outgrowth of neurites and nerve terminals (Chen
et al., 2000). RTN4R is upregulated in the brains of patients
with schizophrenia (Novak et al., 2002). Genetic evidence sup-
ports a role of RTN4R in the etiopathogenesis of schizophrenia
(Novak et al., 2002; Budel et al., 2008). Interestingly, in vitro
experiments demonstrated that cultured neurons expressing the
schizophrenia-associated RTN4R variants failed to respond to the
growth inhibiting activity of myelin, and functioned as a dominant
negative to disrupt endogenous RTN4R (Budel et al., 2008).
Other genes
Oligodendrocyte lineage transcription factor 2 (OLIG2) encodes
a transcription factor central to oligodendrocyte development
(Ross et al., 2003). Genetic association analysis showed thatOLIG2
is associated with schizophrenia and demonstrated an epistatic
effect with 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNP)
and ERBB4 (Georgieva et al., 2006). Furthermore, OLIG2 expres-
sion signiﬁcantly correlated in cerebral cortex with CNP and
ERBB4, suggesting that variation in OLIG2 confers susceptibil-
ity to schizophrenia as part of a network of genes implicated in
oligodendrocyte function. Similarly, a genetic association of the
CNP gene was found for schizophrenia (Peirce et al., 2006). The
CNP risk polymorphism was associated with lower gene expres-
sionwhich is consistentwithCNPgene expressiondownregulation
in schizophrenia.
GENETIC ASSOCIATION OF OMR GENES IN SCHIZOPHRENIA DERIVED
FROM GENOME-WIDE APPROACHES
Signiﬁcant progress has been made over the last decade through
large genome-wide association studies (GWAS). TheGWASdesign
has provided evidence in an agnostic manner that speciﬁc com-
mon DNA genetic variants among people inﬂuence their genetic
susceptibility to multiple different complex disorders, includ-
ing schizophrenia (Ripke et al., 2013). Furthermore, we have
learned that the genetic risk for schizophrenia is highly poly-
genic (Ripke et al., 2013), where the phenotype is inﬂuenced
by multiple genetic variants, each one with small effect sizes.
Here, we present results for association of each OMR gene with
schizophrenia according to the largest published schizophrenia
GWAS data set (PGC-SWE; https://pgc.unc.edu/; Ripke et al.,
2013). No OMR genetic association reached genome-wide sig-
niﬁcance (Table 1); however, a handful of OMR genes (ANK3,
ERBB4, and NRG1) show suggestive association (P < 5 × 10−5).
Future GWAS with increased sample sizes will determine whether
OMR genetic variants are true associations at reduced thresh-
olds, but without the needed power to reach genome-wide
signiﬁcance.
Systems biology approaches allow the integration of multi-
scale datasets gained from genetic imaging and gene and protein
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Table 1 | OMR genes implicated in schizophrenia.
Gene Genetic evidence PGC-SWE P Rank Altered gene expression Altered proteome
ANK3 Athanasiu et al. (2010), Roussos
et al. (2012a), Yuan et al. (2012b)
1.31E−05 2 Roussos et al. (2012a) Cruz et al. (2009),
Roussos et al. (2012a)
CLDN11 9.04E−05 5 Tkachev et al. (2003), Katsel et al. (2005), Dracheva
et al. (2006), Roussos et al. (2012a,b)
CNP Peirce et al. (2006), Voineskos et al.
(2008)
3.94E−03 19 Hakak et al. (2001), Katsel et al. (2005), Dracheva
et al. (2006), McCullumsmith et al. (2007), Barley
et al. (2009), Roussos et al. (2012b)
Prabakaran et al. (2004),
Dracheva et al. (2006)
CNTNAP2 Friedman et al. (2008), Wang et al.
(2010), Ji et al. (2013)
3.95E−04 10 Roussos et al. (2012a)
DISC1 Millar et al. (2000), Saetre et al.
(2008), Song et al. (2008), Rastogi
et al. (2009), Ayalew et al. (2012),
Debono et al. (2012)
1.04E−03 13 Nakata et al. (2009) Ratta-Apha et al. (2013)
ERBB3 Li et al. (2009) 9.70E−05 6 Tkachev et al. (2003), Katsel et al. (2005), Roussos
et al. (2012b)
ERBB4 Norton et al. (2006), Silberberg et al.
(2006), Agim et al. (2013)
2.80E−06 1 Silberberg et al. (2006), Law et al. (2007) Chong et al. (2008)
MAG Wan et al. (2005), Yang et al. (2005) 1.96E−03 16 Tkachev et al. (2003), Katsel et al. (2005), Dracheva
et al. (2006), McCullumsmith et al. (2007), Barley
et al. (2009), Roussos et al. (2012b)
MAL 8.23E−03 21 Hakak et al. (2001), Katsel et al. (2005)
MBP Ayalew et al. (2012) 4.23E−04 11 Tkachev et al. (2003), Matthews et al. (2012) Martins-de-Souza et al.
(2009a,b)
MOBP Ayalew et al. (2012) 6.65E−03 20 Tkachev et al. (2003)
MOG Liu et al. (2005) 1.00E−02 23 Tkachev et al. (2003), Katsel et al. (2005), Barley
et al. (2009), Roussos et al. (2012b)
Martins-de-Souza et al.
(2009a)
NFASC 2.57E−04 8 Roussos et al. (2012a)
NRCAM Ayalew et al. (2012) 1.14E−03 14 Roussos et al. (2012a)
NRG1 Stefansson et al. (2002), Ayalew
et al. (2012), Weickert et al. (2012),
Agim et al. (2013)
3.24E−05 3 Hashimoto et al. (2004), Law et al. (2006), Tan et al.
(2007)
Chong et al. (2008)
OLIG2 Georgieva et al. (2006) 2.13E−03 17 Tkachev et al. (2003), Katsel et al. (2005)
PLP1 Qin et al. (2005) NA NA Tkachev et al. (2003)
PMP22 Kirov et al. (2009) 1.38E−03 15 Katsel et al. (2005), Dracheva et al. (2006)
PTPRZ1 Buxbaum et al. (2008) 6.21E−05 4
QKI Aberg et al. (2006b), Ayalew et al.
(2012)
1.08E−04 7 Katsel et al. (2005), Aberg et al. (2006a),
McCullumsmith et al. (2007)
RTN4R Budel et al. (2008) 6.75E−04 12
SOX10 Maeno et al. (2007), Yuan et al.
(2012a)
8.24E−03 22 Tkachev et al. (2003), Katsel et al. (2005), Dracheva
et al. (2006)
CNTN2 2.57E−04 8 Roussos et al. (2012a,b)
TF Qu et al. (2008) 2.25E−03 18 Hakak et al. (2001), Katsel et al. (2005),
McCullumsmith et al. (2007), Roussos et al. (2012b)
Prabakaran et al. (2004)
The largest PGC-SWE (Ripke et al., 2013) in the form of summary statistic p-values was obtained from public access website (https://pgc.unc.edu/). For each gene
(±100 kb from 5′ and 3′ ends of gene), the strongest P value association is provided in the “PGC-SWE P” column. The “Rank” column indicates the ranking of the
illustrated genes based on the strength of association with the schizophrenia GWAS data set.
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expression studies. The risk SNPs are unlikely to be randomly
distributed, but cluster in molecular subnetworks affecting spe-
ciﬁc cellular populations and molecular processes (Roussos, 2012;
Figure 1A). Recent ﬁndings support the notion that polygenic risk
for schizophrenia affectsOMRgene networks andmolecular path-
ways (Roussos et al., 2012b; Goudriaan et al., 2013). Perturbations
in speciﬁc subnetworks related to neuronal function, myelina-
tion, immune response, and energy production were identiﬁed in
a multi-regional system-level analysis of the schizophrenia brain
transcriptome (Roussos et al., 2012b). The subnetworks related
to neuronal function and myelination were enriched for geneti-
cally associated variants in schizophrenia, providing independent
support for the neuro-oligodendroglial interactions as a potential
causal functional unit in schizophrenia. No enrichment for genetic
variants and immune response and energy production related sub-
networks was found, suggesting that these changes may represent
secondary or bystander phenomena or be attributable to environ-
mental inﬂuences. Similar results were reported in an independent
study, in which the genetic evidence for primary roles of speciﬁc
glial cell type functions and pathways was examined based on gene
set analysis (Goudriaan et al., 2013). In conclusion, recent systems
biology approaches support the notion that schizophrenia involves
hundreds of genetic loci that in combination with environmen-
tal factors converge to perturb a more selective/restrictive set of
molecular/cellular networks and integrative functions.
FUNCTIONAL NEURO-GLIAL UNITS AND THE NODES OF
RANVIER
The above observations suggest that genetic alterations underlying
OMR cell type functions increase susceptibility to schizophrenia
and provide evidence that the “neuron-centric” hypothesis of
schizophrenia should be extended to include a role for glia in
the etiopathogenesis of the disease. The NOR is one of the best
example of the neuroglial cell–cell interactions in the central ner-
vous system. The NORs are myelin-sheath-free segments along
myelinated axons, where sodium ion exchange takes place propa-
gating action potentials from the axon initial segment to the axon
terminal. NOR andOMR gene and protein expression abnormali-
ties can hamper saltatory conduction by affectingNOR formation,
maintenance, and integrity, which in turn leads to failures of salta-
tory conduction and disconnection of higher-order association
areas (Nave, 2010).
Different and speciﬁc neuronal and oligodendroglial recipro-
cal interactions (for review, see Poliak and Peles, 2003) ensure the
high concentration and anchoring of voltage gated Na+ chan-
nels (NaV; NaV1.6 in adults – SCN8A) to the NOR and the
maintenance of adherens junctions between the axolemma and
paranodal myelin loops (Figure 1B). The voltage gated Na+ chan-
nel cytoplasmic loops are linked to the underlying spectrin-actin
cytoskeleton through the anchoring protein Ankyrin G (ANK3).
ANK3 plays an important role in the NOR complex by anchor-
ing not only the NaV to the node but also because several cis
acting nodal and paranodal adherens junction proteins, such as
neurofacin (NFASC), neuronal cell adhesionmolecule (NRCAM),
contactin 1 and caspr, are also associated with it. Finally, contactin
2 (CNTN2), along with Caspr interact in trans with cell adhesion
molecules of oligodendroglial paranodal loops that include an iso-
form of NFASC (Nf155), and CNTN2 to ensure the integrity of
the myelin-axolemma tight junctions, which form a barrier that
prevents the diffusion of Nav from the nodal region.
FIGURE 1 | Neuro-glial functional unit and the disconnectivity
syndrome in schizophrenia. (A) Constellations of multiple genetic
and environmental perturbations affect molecular states of gene
coexpression and protein–protein interaction networks in the neuro-glial
functional unit that in turn increase the risk for schizophrenia. (B) The
NOR is the site of intimate neuroglial cell–cell interactions in the
nervous system. Abnormalities in the expression of NOR genes and
proteins in schizophrenia hamper saltatory conduction by affecting NOR
formation, maintenance and integrity and lead to the disconnectivity
syndrome.
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A recently study demonstrated that several NOR genes and
proteins, includingANK3,NFASC,NRCAM, CNTN2, and SCN8A
are affected in schizophrenia (Roussos et al., 2012a). The impor-
tance of ANK3 to serious mental illness is further supported by
recentGWAS implicatingANK3 in schizophrenia (Athanasiu et al.,
2010) and bipolar disorder (Sklar et al., 2011). Furthermore, an
ANK3 risk polymorphism is associated with decreasedANK3 gene
expression, which is consistent with ANK3 gene expression down-
regulation in schizophrenia andneurocognitive andneuroimaging
abnormalities (Roussos et al., 2012a). Overall, these data highlight
that in addition to OMR changes in schizophrenia, abnormalities
in howmyelin sheaths interact with the axon to form the NOR are
also present and identify the NOR as a functional neuro-glial unit
where neuronal and OMR genetic perturbations could potentially
converge.
CONCLUSION
There are multiple lines of evidence derived from neuroimaging,
molecular and genetic data that support a role of OMR genes and
molecular pathways in schizophrenia. Recent systems biology and
pathway analyses that integrate gene expression and genetic data
support the notion that oligodendroglial abnormalities are among
the primary deﬁcits in the disorder. Future studies need to inte-
grate the larger GWAS and determine the polygenic effect of OMR
genes in schizophrenia. While most efforts in understanding the
cellular basis of schizophrenia have followed a “neuron-centric”
approach, there is an emerging need to conduct more complex
neurobiological studies and examine the neuro-glial unit as a
whole. The data to date provide evidence for abnormalities in
the NOR as a plausible biological substrate for the disconnectiv-
ity syndrome in schizophrenia. Recent evidence suggesting that
antipsychotics may inﬂuence OMR function beneﬁcially provides
clues for improved treatment strategies (Ren et al., 2013). There-
fore, a more thorough understanding of the role of OMR and
NOR pathophysiology is necessary since it holds the potential for
providing new insights into the treatment of this disease.
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